All In Biotech

Drug Trial Radar · NCT07421297

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

A Phase Ⅲ Randomized, Parallel-group, Placebo-controlled Trial to Assess the Efficacy, Safety of the SYH2053 Subcutaneous Injection as Monotherapy in Participants With Primary Hypercholesterolemia (Non-familial) or Mixed Dyslipidemia

Last checked: Nov 19, 2026Latest source record: Apr 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 760 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

760

Planned (sponsor's estimate)

Start

Feb 28, 2026

Primary completion

Dec 31, 2027

Study completion Jan 31, 2028

Sponsor

Sponsor type
Industry
First posted
Feb 19, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of SYH2053 monotherapy in patients with primary hypercholesterolemia (non-familial) or mixed dyslipidemia . This trial plans to enroll 760 Participants.

Conditions

  • Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Interventions

  • SYH2053 injectionDrug

    Participants receive SYH2053 injection by subcutaneous administration.

  • SYH2053 injection placeboOther

    Participants receive SYH2053 injection placebo by subcutaneous administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage change in LDL-C relative to baselineTime frame: Day 330

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Affiliation: Peking University Third Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Affiliation: Peking University Third Hospital

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.